Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy

NCT07360002 is registered in ClinicalTrials.gov with Keda Lu as lead sponsor.

NCT NCT07360002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07360002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomized Controlled Study of Shenqi Yishen Granules in the Treatment of IgA Nephropathy
Lead sponsor
Keda Lu
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
December 31, 2026
Enrollment
102 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

iga nephropathy (igan)